Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series

Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review

(2021) Anuraag Jena et al.   INFLAMMATORY BOWEL DISEASES

Sequential use of high-dose tofacitinib after infliximab salvage therapy in acute severe ulcerative colitis

(2021) Robert Gilmore et al.   Journal of Crohns & Colitis

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

(2020) Joseph D. Feuerstein et al.   GASTROENTEROLOGY

Tofacitinib for rescue therapy in acute severe ulcerative colitis: a real-world experience

(2020) Prashant Kotwani et al.   Journal of Crohns & Colitis

Tofacitinib in Acute Severe Ulcerative Colitis—A Real-World Tertiary Center Experience

(2020) Sailish Honap et al.   INFLAMMATORY BOWEL DISEASES

Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

(2018) Stephen Hanauer et al.   Clinical Gastroenterology and Hepatology

Efficacy of Induction Therapy with High-intensity Tofacitinib in 4 Patients with Acute Severe Ulcerative Colitis

(2018) Jeffrey A. Berinstein et al.   Clinical Gastroenterology and Hepatology

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

(2012) David Laharie et al.   LANCET

Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements

(2011) Alain Bitton et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY